PubMed:37085694
Annnotations
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 95-113 | Disease | denotes | metabolic syndrome | http://purl.obolibrary.org/obo/MONDO_0004955 |
T2 | 129-147 | Disease | denotes | metabolic syndrome | http://purl.obolibrary.org/obo/MONDO_0004955 |
T3 | 149-153 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T4 | 215-234 | Disease | denotes | atrial fibrillation | http://purl.obolibrary.org/obo/MONDO_0004981 |
T5 | 258-262 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T6 | 544-548 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T7 | 577-581 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T8 | 615-619 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T9 | 621-625 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T10 | 731-735 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T11 | 1009-1013 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T12 | 1147-1151 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T13 | 1237-1241 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T14 | 1678-1682 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
Glycan-GlyCosmos
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 1030-1049 | Glycan | denotes | galactosyl ceramide | https://api.glycosmos.org/wurcs2image/latest/png/binary/G65889KE |
GlyCosmos-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 1030-1049 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | galactosyl ceramide | http://www.glycoepitope.jp/epitopes/EP0074 |
GlyCosmos15-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 215-234 | Phenotype | denotes | atrial fibrillation | HP:0005110 |
GlyCosmos15-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 95-113 | Disease | denotes | metabolic syndrome | http://purl.obolibrary.org/obo/MONDO_0004955 |
T2 | 129-147 | Disease | denotes | metabolic syndrome | http://purl.obolibrary.org/obo/MONDO_0004955 |
T3 | 149-153 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T4 | 215-234 | Disease | denotes | atrial fibrillation | http://purl.obolibrary.org/obo/MONDO_0004981 |
T5 | 258-262 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T6 | 544-548 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T7 | 577-581 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T8 | 615-619 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T9 | 621-625 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T10 | 731-735 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T11 | 1009-1013 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T12 | 1147-1151 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T13 | 1237-1241 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
T14 | 1678-1682 | Disease | denotes | MetS | http://purl.obolibrary.org/obo/MONDO_0004955 |
GlyCosmos15-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 503-508 | Body_part | denotes | Blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
GlyCosmos15-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 503-508 | Body_part | denotes | Blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-114 | Sentence | denotes | Association of lipid composition and unsaturated fatty acids of VLDL with atrial remodeling in metabolic syndrome. |
T2 | 115-235 | Sentence | denotes | Subjects with metabolic syndrome (MetS) commonly have atrial remodeling, which indicates a risk for atrial fibrillation. |
T3 | 236-502 | Sentence | denotes | This study determined MetS-related changes in lipid components in very-low-density lipoprotein (VLDL), which has been shown to cause atrial remodeling, the effect of statins on these changes, and the correlation between atrial remodeling and VLDL lipid compositions. |
T4 | 503-591 | Sentence | denotes | Blood samples were collected from 12 non-MetS and 27 sex- and age-matched MetS subjects. |
T5 | 592-747 | Sentence | denotes | Fourteen patients with MetS (MetS-off statin) discontinued statin therapy 14 days before the study, while the remaining 13 remained on it (MetS-on statin). |
T6 | 748-817 | Sentence | denotes | The VLDLs were isolated and processed for mass-based lipid profiling. |
T7 | 818-963 | Sentence | denotes | Lipidomic analyses were performed and associated with atrial remodeling markers measured using standard echocardiography and electrocardiography. |
T8 | 964-1169 | Sentence | denotes | Compared with the VLDL components of the non-MetS group, glucosyl/galactosyl ceramide, lyso-phosphatidylcholine, lyso-phosphatidylethanolamine, and triglycerides were enriched in the MetS-off statin group. |
T9 | 1170-1268 | Sentence | denotes | Statin therapy attenuated all abnormally abundant lipid classes in MetS, except for triglycerides. |
T10 | 1269-1472 | Sentence | denotes | In addition, lyso-phosphatidylcholine, lyso-phosphatidylethanolamine, and triglycerides were significantly correlated with atrial dilatation, and the latter two were also correlated with the PR interval. |
T11 | 1473-1618 | Sentence | denotes | Enrichment of double bonds, which indicate unsaturated fatty acids, was also significantly correlated with atrial remodeling and P-wave duration. |
T12 | 1619-1736 | Sentence | denotes | This study suggests that the pathological lipid payload of MetS-VLDL may contribute to atrial remodeling in patients. |
GlyCosmos15-Glycan
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 1030-1049 | Glycan | denotes | galactosyl ceramide | https://api.glycosmos.org/wurcs2image/latest/png/binary/G65889KE |
GlyCosmos15-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 1030-1049 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | galactosyl ceramide | http://www.glycoepitope.jp/epitopes/EP0074 |
Anatomy-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 503-508 | Body_part | denotes | Blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 503-508 | Body_part | denotes | Blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 215-234 | Phenotype | denotes | atrial fibrillation | HP:0005110 |